Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Bausch + Lomb Corporation (BLCO)

Bausch + Lomb Corp (BLCO) - logo korporat

The quarterly relative change in EPS demonstrates the impact of high debt leverage and market pressure on the cash flow of Bausch + Lomb Corporation (BLCO). Meanwhile, 211.30 represents the current value of this metric. Stable revenue is driven by customer reliance on consumables, while the brand's impeccable reputation among ophthalmologists ensures business resilience regardless of external perception crises.

bausch.com (BLCO) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan saka 28.04.2023 nganti 18.11.2026

BLCO (bausch.com): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Analisis kabeh metrik perusahaan:Bausch Health - BLCO
Produk dadi Bausch + Lomb Corporation

Quarterly EPS growth measures the dynamics of net income per share, revealing the pace of business scaling or stagnation. This metric is calculated as the percentage deviation of the current result from the same period last year. By analyzing the quarter-over-quarter EPS growth rate, an investor assesses the sustainability of cash flows. For Bausch + Lomb Corporation (BLCO), this trend reflects the impact of debt load and marketing expenses. A decline in this indicator may signal cost pressure on overall profitability.

Pesaing utama

Alcon Corp (ALC) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Glaukos Medical (GKOS)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan apellis.com|Belite Bio (BLTE) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Ocular Pharma (OCUL)|HROW (Harrow) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan VRDN (Viridian Corp)|LENZ Corp (LENZ) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|OCS: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan eyepointpharma.com|KOD: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Aldeyra Therapeutics (ALDX)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan KALA|IRD - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan okyopharma.com (OKYO)|Wutah bathi EPS kuartalan Adverum Biotechnologies Inc. (ADVM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan outlooktherapeutics.com OTLK|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Clearside Biomedical, Inc. (CLSD)|NBY - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Eyenovia Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|GHSI (Guardion Health Sciences) - Wutah bathi EPS kuartalan|Ocuphire Pharma - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OPT (Opthea)